title: Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study)
abstract: A deficiency of protein C (PC), antithrombin, or protein S is strongly associated with deep-vein thrombosis in selected patients and their families. However, the strength of the association with venous thrombosis in the general population is unknown. This study was a population-based, patient-control study of 474 consecutive outpatients, aged less than 70 years, with a first, objectively diagnosed, episode of venous thrombosis and without an underlying malignant disease, and 474 healthy controls who matched for age and sex. Relative risks were estimated as matched odds ratios. Based on a single measurement, there were 22 (4.6%) patients with a PC deficiency (PC activity, less than 0.67 U/mL or PC antigen, less than 0.33 U/mL when using coumarins). Among the controls, the frequency was 1.5% (seven subjects). Thus, there is a threefold increase in risk of thrombosis in subjects with PC levels below 0.67 or 0.33 U/mL [matched odds ratio, 3.1; 95% confidence interval (CI), 1.4 to 7.0]. When a PC deficiency was based on two repeated measurements, the relative risk for thrombosis increased to 3.8 (95% CI, 1.3 to 10); when it was based on DNA-confirmation, the relative risk increased further to 6.5 (95% CI, 1.8 to 24). In addition, there was a gradient in thrombosis risk, according to PC levels. The results for antithrombin are similar to those for PC, although less pronounced (relative risk, 2.2; 95% CI, 1.0 to 4.7). We could not find an association between reduced total protein S (relative risk, 0.7; 95% CI, 0.3 to 1.8) or free protein S levels (relative risk, 1.6; 95% CI, 0.6 to 4.0) and thrombosis risk. Although not very frequent, PC and antithrombin deficiency are clearly associated with an increase in thrombosis risk.
authors.affiliation: Department of Clinical Epidemiology, University Hospital Leiden, The Netherlands.
authors.forename: T
authors.initials: T
authors.lastname: Koster
authors.forename: F R
authors.initials: FR
authors.lastname: Rosendaal
authors.forename: E
authors.initials: E
authors.lastname: Briët
authors.forename: F J
authors.initials: FJ
authors.lastname: van der Meer
authors.forename: L P
authors.initials: LP
authors.lastname: Colly
authors.forename: P H
authors.initials: PH
authors.lastname: Trienekens
authors.forename: S R
authors.initials: SR
authors.lastname: Poort
authors.forename: P H
authors.initials: PH
authors.lastname: Reitsma
authors.forename: J P
authors.initials: JP
authors.lastname: Vandenbroucke
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017354:Point Mutation; D011486:Protein C / Q000235:genetics; D020151:Protein C Deficiency; D012307:Risk Factors; D013924:Thrombophlebitis / Q000201:enzymology* / Q000235:genetics
chemical_list: D011486:Protein C